U. Prasad

2.1k total citations
42 papers, 1.6k citations indexed

About

U. Prasad is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, U. Prasad has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in U. Prasad's work include Viral-associated cancers and disorders (23 papers), Parvovirus B19 Infection Studies (12 papers) and Head and Neck Cancer Studies (8 papers). U. Prasad is often cited by papers focused on Viral-associated cancers and disorders (23 papers), Parvovirus B19 Infection Studies (12 papers) and Head and Neck Cancer Studies (8 papers). U. Prasad collaborates with scholars based in Malaysia, United States and Sweden. U. Prasad's co-authors include Nancy Raab‐Traub, Robert H. Sadler, K Flynn, Pathmanathan Rajadurai, Choon‐Kook Sam, R Pathmanathan, Gerald Niedobitek, Lawrence S. Young, Jingwu Xu and Ali Ahmad and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

U. Prasad

41 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Prasad Malaysia 19 1.2k 372 343 299 272 42 1.6k
Pathmanathan Rajadurai Malaysia 20 1.1k 0.8× 240 0.6× 304 0.9× 121 0.4× 202 0.7× 60 1.7k
Taizo Tasaka Japan 23 936 0.8× 197 0.5× 496 1.4× 21 0.1× 155 0.6× 91 2.0k
R Jlidi Tunisia 15 373 0.3× 68 0.2× 124 0.4× 121 0.4× 58 0.2× 79 819
Osamu Saiki Japan 21 233 0.2× 69 0.2× 78 0.2× 234 0.8× 788 2.9× 52 1.4k
Shu‐Chen Huang Taiwan 12 283 0.2× 77 0.2× 203 0.6× 186 0.6× 57 0.2× 20 772
Toshinao Takenouchi Japan 19 416 0.3× 83 0.2× 153 0.4× 28 0.1× 372 1.4× 49 1.2k
Maria Andersson‐Anvret Sweden 12 405 0.3× 202 0.5× 173 0.5× 38 0.1× 90 0.3× 19 565
Debora Martorelli Italy 20 564 0.5× 92 0.2× 149 0.4× 17 0.1× 369 1.4× 34 989
Wing Y. Chan China 15 345 0.3× 163 0.4× 253 0.7× 15 0.1× 167 0.6× 25 802
Caroline Alfieri Canada 21 1.5k 1.2× 585 1.6× 675 2.0× 6 0.0× 493 1.8× 38 2.0k

Countries citing papers authored by U. Prasad

Since Specialization
Citations

This map shows the geographic impact of U. Prasad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Prasad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Prasad more than expected).

Fields of papers citing papers by U. Prasad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Prasad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Prasad. The network helps show where U. Prasad may publish in the future.

Co-authorship network of co-authors of U. Prasad

This figure shows the co-authorship network connecting the top 25 collaborators of U. Prasad. A scholar is included among the top collaborators of U. Prasad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Prasad. U. Prasad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prasad, U., et al.. (2002). Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 53(3). 648–655. 15 indexed citations
2.
Lim, Yang Mooi, A. W. Norhanom, Nordin H. Lajis, et al.. (2000). Anti-tumor Promoting Activity of Some Malaysian Traditional Vegetable (Ulam) Extracts by Immunoblotting Analysis of Raji Cells. Natural Product Sciences. 6(3). 147–150. 10 indexed citations
3.
Xu, Jingwu, Ali Ahmad, Mario D’Addario, et al.. (2000). Analysis and Significance of Anti-Latent Membrane Protein-1 Antibodies in the Sera of Patients with EBV-Associated Diseases. The Journal of Immunology. 164(5). 2815–2822. 31 indexed citations
4.
Xu, Jingwu, Ali Ahmad, Mario D’Addario, et al.. (1998). The Epstein-Barr Virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases. International Journal of Cancer. 79(5). 481–486. 25 indexed citations
5.
Prasad, U., Pathmanathan Rajadurai, Giancarlo Pizza, et al.. (1996). Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: A pilot study. Biotherapy. 9(1-3). 109–115. 10 indexed citations
6.
Rajadurai, Pathmanathan, U. Prasad, Robert H. Sadler, K Flynn, & Nancy Raab‐Traub. (1995). Clonal Proliferations of Cells Infected with Epstein–Barr Virus in Preinvasive Lesions Related to Nasopharyngeal Carcinoma. New England Journal of Medicine. 333(11). 693–698. 473 indexed citations
7.
Cheng, Hwee‐Ming, et al.. (1995). Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma. Cancer Immunology Immunotherapy. 40(4). 251–256. 3 indexed citations
8.
Cheng, Hwee‐Ming, et al.. (1994). A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunology Immunotherapy. 38(1). 68–70. 29 indexed citations
9.
Cheng, Hwee‐Ming, et al.. (1994). Serum IgA Cross-Reactivity between Glycine-Alanine Repeat Sequence of EBNA-1 and Keratin or Collagen in Nasopharyngeal Carcinoma. Clinical Immunology and Immunopathology. 71(2). 164–168. 2 indexed citations
10.
Dugan, Margaret, Damon Choy, A. Ngai, et al.. (1993). Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group study.. Journal of Clinical Oncology. 11(1). 70–76. 30 indexed citations
11.
12.
Sam, Choon‐Kook, L. Brooks, Gerald Niedobitek, et al.. (1993). Analysis of epstein‐barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. International Journal of Cancer. 53(6). 957–962. 85 indexed citations
13.
Niedobitek, Gerald, Lawrence S. Young, Choon‐Kook Sam, et al.. (1992). Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.. PubMed Central. 140(4). 879–87. 117 indexed citations
14.
Yao, Q. Y., Martin Rowe, Anthony J. Morgan, et al.. (1991). Salivary and serum IgA antibodies to the epstein—barr virus glycoprotein gp340: incidence and potential for virus neutralization. International Journal of Cancer. 48(1). 45–50. 40 indexed citations
15.
Sam, Choon‐Kook, et al.. (1990). Detection of Epstein-Barr virus DNA in nasopharyngeal carcinoma using a non-radioactive digoxigenin-labelled probe. Journal of Virological Methods. 27(3). 261–267. 10 indexed citations
16.
Cheng, H. M., et al.. (1990). Serum and salivary IgA antibodies against a defined epitope of the Epstein‐Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma. International Journal of Cancer. 45(6). 1061–1064. 42 indexed citations
17.
Thoe, Su Yun Se, Choon‐Kook Sam, H. M. Cheng, & U. Prasad. (1989). Improved Sensitivity of Detection by Avidin—Biotin Complex (ABC) Immunocytochemistry in Epstein‐Barr Virus Serology. Journal of Medical Virology. 29(4). 311–314. 4 indexed citations
18.
Prasad, U.. (1979). Fossa of Rosenmuller and nasopharyngeal carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 33(3). 222–5. 5 indexed citations
19.
Prasad, U.. (1978). Nasopharyngeal carcinoma. Aetiological aspects and electronmicroscopic observations.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(4). 199–207. 1 indexed citations
20.
Shanmugaratnam, K., Ho Jh, U. Prasad, et al.. (1978). Nasopharyngeal carcinoma and histocompatibility antigens.. PubMed. 271–82. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pathmanathan Rajadurai Breakdown of academic impact, for papers by Taizo Tasaka Breakdown of academic impact, for papers by R Jlidi Breakdown of academic impact, for papers by Osamu Saiki Breakdown of academic impact, for papers by Shu‐Chen Huang Breakdown of academic impact, for papers by Toshinao Takenouchi Breakdown of academic impact, for papers by Maria Andersson‐Anvret Breakdown of academic impact, for papers by Debora Martorelli Breakdown of academic impact, for papers by Wing Y. Chan Breakdown of academic impact, for papers by Caroline Alfieri
Rankless by CCL
2026